Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes

Biopatents frequently disclose sequences of polypeptides and nucleic acids in the written description. The claims often cover a homology range surrounding the disclosed sequence to get a broader protection. However, homology claims face a hurdle that they may lack support by the written description....

Full description

Saved in:
Bibliographic Details
Main Author: Yang, Qinghua (auth)
Format: Electronic Book Chapter
Language:English
Published: Nomos Verlagsgesellschaft mbH & Co. KG 2018
Series:Munich Intellectual Property Law Center - MIPLC
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_40386
005 20210211
003 oapen
006 m o d
007 cr|mn|---annan
008 20210211s2018 xx |||||o ||| 0|eng d
020 |a /dx.doi.org/10.5771/9783845292717 
020 |a 9783845292717 
040 |a oapen  |c oapen 
024 7 |a http://dx.doi.org/10.5771/9783845292717  |c doi 
041 0 |a eng 
042 |a dc 
100 1 |a Yang, Qinghua  |4 auth 
245 1 0 |a Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes 
260 |b Nomos Verlagsgesellschaft mbH & Co. KG  |c 2018 
300 |a 1 electronic resource (72 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Munich Intellectual Property Law Center - MIPLC 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Biopatents frequently disclose sequences of polypeptides and nucleic acids in the written description. The claims often cover a homology range surrounding the disclosed sequence to get a broader protection. However, homology claims face a hurdle that they may lack support by the written description. The Supreme Court of China ruled that homology claims lack support, but a further limitation by species of origin satisfies this requirement. This study explains that homology per se should have formed the essence of such disputes. Homology dictates the skilled person's confidence on the functionality of unknown sequences, and is involved in multiple patentability requirements. Thus, the assessment of support is not an isolated matter. Disparity of different requirements creates an unclaimable gap, and constitutes a discrimination to biotechnology. An appropriate test for the support requirement is thus furnished to confer a scope of protection commensurating to the technical contribution. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
653 |a polypeptide 
653 |a homology 
653 |a Achilles Heel 
653 |a Biopatents 
653 |a Novozymes 
653 |a Chinese patent law 
653 |a protein 
653 |a Aegis Heel 
653 |a support requirement 
653 |a Dilemma of Homology 
856 4 0 |a www.oapen.org  |u https://www.nomos-elibrary.de/10.5771/9783845292717  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/40386  |7 0  |z DOAB: description of the publication